ErepoXen

Type: Product
Name: ErepoXen
First reported Sep 22 2014 - Updated Sep 22 2014 - 1 reports

Xenetic Biosciences to Hold Business Update Conference Call September 23 at 6:00 a.m. Eastern Time

Xenetic Biosciences, Inc. ( OTCBB: XBIO ), a biopharmaceuticalcompany focused on developing next-generation biologic drugs and noveloncology therapeutics, today announced that it will hold a businessupdate conference call on Tuesday, September 23, 2014 ... [Published Franklin Credit Management Corporation - Sep 22 2014]
First reported Jun 12 2014 - Updated Jun 12 2014 - 1 reports

Xenetic doses first patient on dialysis in Phase II trial of ErepoXen

US-based biopharmaceutical firm Xenetic Biosciences has announced that its partner, the Serum Institute of India, has started dosing patients in the second group of a Phase IIa clinical, sequential single dose trial of intravenously (IV) administered ... [Published PBR - News - Jun 12 2014]

More Content

All (5) | News (1) | Reports (0) | Blogs (1) | Audio/Video (0) | Fact Sheets (0) | Press Releases (3)
sort by: Date | Relevance
Xenetic Biosciences to Hold Business Update Con... [Published Franklin Credit Management Corporation - Sep 22 2014]
Xenetic Biosciences Announces Ongoing Safety Da... [Published GlobeNewswire: Acquisitions News - Jun 30 2014]
Xenetic doses first patient on dialysis in Phas... [Published PBR - News - Jun 12 2014]
Xenetic Biosciences Announces Dosing of First P... [Published GlobeNewswire: Acquisitions News - Jun 11 2014]
Xenetic Biosciences Strengthens Technology Pate... [Published GlobeNewswire: Advertising News - Jun 09 2014]
1
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
Xenetic doses first patient on dialysis in Phas... [Published PBR - News - Jun 12 2014]
US-based biopharmaceutical firm Xenetic Biosciences has announced that its partner, the Serum Institute of India, has started dosing patients in the second group of a Phase IIa clinical, sequential single dose trial of intravenously (IV) administered ...
1

Press Releases

sort by: Date | Relevance
Xenetic Biosciences Announces Ongoing Safety Da... [Published GlobeNewswire: Acquisitions News - Jun 30 2014]
Xenetic Biosciences Announces Dosing of First P... [Published GlobeNewswire: Acquisitions News - Jun 11 2014]
Xenetic Biosciences Strengthens Technology Pate... [Published GlobeNewswire: Advertising News - Jun 09 2014]
1
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.